|
|
|
|
|
|
|
|
|
|
|
|
|
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0001102939
<NAME> BIOPULSE INTERNATIONAL, INC.
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> JUL-31-1999
<PERIOD-END> APR-30-2000
<CASH> 51,135
<SECURITIES> 0
<RECEIVABLES> 6,435
<ALLOWANCES> 0
<INVENTORY> 79,445
<CURRENT-ASSETS> 0
<PP&E> 588,226
<DEPRECIATION> 46,437
<TOTAL-ASSETS> 1,066,514
<CURRENT-LIABILITIES> 288,840
<BONDS> 0
0
50
<COMMON> 6,074
<OTHER-SE> 771,550
<TOTAL-LIABILITY-AND-EQUITY> 1,066,514
<SALES> 1,119,915
<TOTAL-REVENUES> 0
<CGS> 360,602
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 373,770
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 385,543
<INCOME-TAX> 0
<INCOME-CONTINUING> 385,543
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 385,543
<EPS-BASIC> 0.06
<EPS-DILUTED> 0.06
</TABLE>
|
|